Neuropathologic Alterations in Mild Cognitive Impairment: A Review
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Mild cognitive impairment (MCI), the earliest clinically detectable phase of the trajectory toward dementia and Alzheimer's disease (AD), led to the need for even earlier detection and prevention of AD. Although it is a clinical diagnosis, its underlying neuropathological findings are just being defined. MCI is best studied in longitudinally followed patients in centers that are experienced in dementing disorders. In this review of the few major clinical-pathological reports of longitudinally followed patients, it appears that most autopsied amnestic MCI (aMCI) patients are on a pathway toward AD. Neurofibrillary pathology in entorhinal cortex, hippocampus, and amygdala--not amyloid plaques--is the major substrate for aMCI and for memory decline. In addition, many MCI patients have other concomitant pathological alterations, the most common of which are strokes, but also include argyrophilic grains and Lewy bodies. These findings are not surprising because most MCI autopsied cases have been in the older (80 to 90 year) range where these findings are common. In early AD, the phase following MCI, the significant change is an increase in neurofibrillary tangles in the neocortex that correlates with an increase in Braak score and the observed clinical progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AD pathology occurs well before (up to two decades) the onset of clinical symptoms2–4.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [3]
In the citing paper
“It has been estimated that approximately 15 percent of people with aMCI progress to AD annually3.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [3]
In the citing paper
“Indeed, the first pathological insults to neurons in AD and aMCI occur at pre- and post-synaptic membranes1,3.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [3]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 4×
“The National Institute on Aging and Reagan Institute (NIA-RI) criteria, developed in 1997 [9], use the CERAD plaque score and the Braak and Braak score to reach a likelihood of the diagnosis of AD.”
ResultInfluentialMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084 · cited 1×
“[2] in two seminal publications to describe that the”
BackgroundMild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,851 · cited 2×
“In another report from Washington University’s Alzheimer’s Disease Research Center [17], they found that in six subjects with CDR scores of 0.5 with uncertain dementia at entry into this study, all had neuropathological AD at autopsy.”
BackgroundInfluentialHYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336 · cited 1×
“[28] reported that, of 134 persons without cognitive impairment from the Religious Order Study and Rush Memory and Aging Project, at autopsy two met NIA-RI high likelihood criteria, 48 met intermediate likelihood criteria, and 79 met low likelihood criteria; 29 had cerebral infarctions; and 18 had Lewy bodies.”
BackgroundHippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017 · cited 1×
“Scheff and colleagues [23,24] showed that synapse numbers were decreased in the stratum radiation of hippocampal CA1 and the outer molecular layer of the dentate gyrus in aMCI longitudinally followed patients”
BackgroundConsensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease
(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD
Jack, C. R., Shiung, M. M., Gunter, J. L., O’Brien, P. C., Weigand, S. D., Knopman, D. S., Boeve, B. F., Ivnik, R. J., Smith, G. E., Cha, R. H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000110315.26026.ef · Cited by 827
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., DeKosky, S. T., & Mufson, E. J. (2007) · Neurology · doi:10.1212/01.wnl.0000260698.46517.8f · Cited by 824 · cited 1×
“Scheff and colleagues [23,24] showed that synapse numbers were decreased in the stratum radiation of hippocampal CA1 and the outer molecular layer of the dentate gyrus in aMCI longitudinally followed patients”
BackgroundNeuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Nelson, P. T., Braak, H., & Markesbery, W. R. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181919a48 · Cited by 643 · cited 1×
“neuropathologic features of AD [30] characterized by”
Self-citationNeuropathologic Features of Amnestic Mild Cognitive Impairment
Petersen, R. C., Parisi, J. E., Dickson, D. W., Johnson, K. A., Knopman, D. S., Boeve, B. F., Jicha, G. A., Ivnik, R. J., Smith, G. E., Tangalos, E. G., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.665 · Cited by 616 · cited 1×
“Petersen and colleagues [18] reported the neuropathologic findings in 15 longitudinally followed subjects from a community-based study that died while their clinical diagnosis was aMCI.”
BackgroundMild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions
Bennett, D. A., Schneider, J. A., Bienias, J. L., Evans, D. A., & Wilson, R. S. (2005) · Neurology · doi:10.1212/01.wnl.0000152982.47274.9e · Cited by 537 · cited 2×
“A report from the Religious Order Study of 37 longitudinally followed MCI subjects compared to 60 without cognitive decline and 83 demented subjects showed that MCI patients had intermediate AD pathology between normal and demented subjects [16].”
BackgroundBrain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI
Jack, C. R., Shiung, M. M., Weigand, S. D., O’Brien, P. C., Gunter, J. L., Boeve, B. F., Knopman, D. S., Smith, G. E., Ivnik, R. J., Tangalos, E. G., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000180958.22678.91 · Cited by 492
Neuropathologic Substrate of Mild Cognitive Impairment
Markesbery, W. R., Schmitt, F. A., Kryscio, R. J., Davis, D. G., Smith, C. D., & Wekstein, D. R. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.38 · Cited by 460 · cited 1×
“Our study used 10 aMCI patients compared with 10 early AD (EAD) patients and 23 normal controls [15].”
ResultSelf-citationNeuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical Dementia
Jicha, G. A., Parisi, J. E., Dickson, D. W., Johnson, K., Cha, R., Ivnik, R. J., Tangalos, E. G., Boeve, B. F., Knopman, D. S., Braak, H., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.674 · Cited by 399 · cited 1×
“[11] described followup of 34 patients from a community-based cohort with MCI who progressed to dementia and eventually underwent postmortem brain analysis.”
BackgroundGrudzien, A., Shaw, P., Weintraub, S., Bigio, E., Mash, D. C., & Mesulam, M. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.007 · Cited by 396 · cited 1×
“Two reports of four longitudinally followed MCI patients compared to seven normal controls revealed that those with MCI had significantly increased NFT in the nucleus basalis of Meynert [21] and locus ceruleus [22], indicating that alterations in these structures were an early event in the aging-MCI-AD continuum.”
ResultRiley, K. P., Snowdon, D. A., & Markesbery, W. R. (2002) · Annals of Neurology · doi:10.1002/ana.10161 · Cited by 392 · cited 1×
“In a study of autopsied nuns [14], a complex system to classify subjects into two large groups was used: one group included subjects with normal memory that were either intact, had mild impairments, or had global impairment.”
MethodSelf-citationCholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum
Mesulam, M., Shaw, P., Mash, D., & Weintraub, S. (2004) · Annals of Neurology · doi:10.1002/ana.20100 · Cited by 374 · cited 1×
“Two reports of four longitudinally followed MCI patients compared to seven normal controls revealed that those with MCI had significantly increased NFT in the nucleus basalis of Meynert [21] and locus ceruleus [22], indicating that alterations in these structures were an early event in the aging-MCI-AD continuum.”
Result“Preclinical” AD revisited: Neuropathology of cognitively normal older adults
Schmitt, F. A., Davis, D. G., Wekstein, D. R., Smith, C. D., Ashford, J. W., & Markesbery, W. R. (2000) · Neurology · doi:10.1212/wnl.55.3.370 · Cited by 369
Self-citationROTH, M., TOMLINSON, B. E., & BLESSED, G. (1966) · Nature · doi:10.1038/209109a0 · Cited by 298
Mitchell, T. W., Mufson, E. J., Schneider, J. A., Cochran, E. J., Nissanov, J., Han, L., Bienias, J. L., Lee, V. M. ‐., Trojanowski, J. Q., Bennett, D. A., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10086 · Cited by 253 · cited 1×
“Mitchell and collaborators [13] studied NFT and neuropil threads (using tau immunohistochemistry and quantitative image analysis) in entorhinal and perirhinal cortices in 14 normal controls, 9 MCI, and 8 AD patients from the Religious Order Study.”
BackgroundMild Cognitive Impairment Is Early-Stage Alzheimer Disease: Time to Revise Diagnostic Criteria
Morris, J. C. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.15 · Cited by 178 · cited 2×
“In 1999, Price and Morris [12] studied 15 longitudinally followed patients with Clinical Dementia Rating (CDR) Scale scores of 0.5 and found all patients had neuropathologic changes of AD at autopsy.”
BackgroundInfluentialBrain structural alterations before mild cognitive impairment
Smith, C. D., Chebrolu, H., Wekstein, D. R., Schmitt, F. A., Jicha, G. A., Cooper, G., & Markesbery, W. R. (2007) · Neurology · doi:10.1212/01.wnl.0000259542.54830.34 · Cited by 161
Self-citationFactors associated with resistance to dementia despite high Alzheimer disease pathology
Erten-Lyons, D., Woltjer, R. L., Dodge, H., Nixon, R., Vorobik, R., Calvert, J. F., Leahy, M., Montine, T., & Kaye, J. (2009) · Neurology · doi:10.1212/01.wnl.0000341273.18141.64 · Cited by 147
Neuropathology of mild cognitive impairment
Saito, Y., & Murayama, S. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00806.x · Cited by 92
Brain Donation in Normal Aging
Schmitt, F. A., Wetherby, M. M. C., Wekstein, D. R., Dearth, C. M. S., & Markesbery, W. R. (2001) · The Gerontologist · doi:10.1093/geront/41.6.716 · Cited by 88 · cited 1×
“All were followed longitudinally as part of our normal aging study and were evaluated annually as described previously [20].”
MethodSelf-citationImaging Alzheimer's disease pathology: one target, many ligands
Lockhart, A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.008 · Cited by 61 · cited 12×
“By the same token, reviewing PCAD cases in a blinded manner does not allow one to differentiate them from MCI or EAD on a purely neuropathologic basis.”
BackgroundInfluentialPredictors of Preclinical Alzheimer Disease and Dementia: A Clinicopathologic Study
Galvin, J. E., Powlishta, K. K., Wilkins, K., McKeel, D. W., Xiong, C., Grant, E., Storandt, M., & Morris, J. C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.5.758 · Cited by 2
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Cited by
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects
Moradi, E., Pepe, A., Gaser, C., Huttunen, H., & Tohka, J. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2014.10.002 · Cited by 708
“Mild cognitive impairment (MCI) is a transitional stage between age-related cognitive decline and AD, and the earliest clinically detectable stage of progression towards dementia or AD (Markesbery, 2010).”
Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
Jellinger, K. A. (2012) · Movement Disorders · doi:10.1002/mds.23795 · Cited by 451
Saygin, Z. M., Kliemann, D., Iglesias, J. E., van der Kouwe, A. J. W., Boyd, E., Reuter, M., Stevens, A., Van Leemput, K., McKee, A., Frosch, M. P., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.04.046 · Cited by 467
“For the ADNI comparison, we expected gross anatomical differences between the pathological and the control group, given the neuropathology in AD and MCI (Markesbery, 2010; Yilmazer-Hanke, 1998).”
BackgroundMethodInfluentialSpasov, S., Passamonti, L., Duggento, A., Liò, P., & Toschi, N. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.01.031 · Cited by 425
Metadata
- Authors
- Markesbery, W. R.
- Affiliations
- University of Kentucky (US)
- Corresponding author
- Markesbery, William R.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-01-06
- Volume
- 19
- Issue
- 1
- Pages
- 221-228
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC2872776
- OpenAlex
- W1554171816
- Cited by
- 236
- References
- 35
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 12 · 2023: 13 · 2022: 12 · 2021: 16 · 2020: 18 · 2019: 8 · 2018: 11 · 2017: 14 · 2016: 16 · 2015: 17 · 2014: 13 · 2013: 17 · 2012: 22
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (P30AG028383, P01AG005119, AG0 5119)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- mild cognitive impairment, Alzheimer's disease
- MeSH terms
- Age Factors, Alzheimer Disease, Animals, Cognition Disorders, Humans, Neurofibrillary Tangles, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.